The Study of CYP2C19 Genotype-Guided Clopidogrel Treatment Models

Clinical trial NCT06665919 · COMPLETED

Trial details

NCT number: NCT06665919
Sponsor: Vistamedi Ltd.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Coronary Artery Disease Clopidogrel Resistance Coronary Thrombosis Adverse Cardiac Events Bleeding Hospitalisations Death Death From Cardiovascular Disease

Start date: 2023-06-15
Primary completion: 2025-05-15
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.